Patsy G Oliver Selected Research

tigatuzumab

6/2012	Effect of anti-DR5 and chemotherapy on basal-like breast cancer.
7/2009	Effect of TRA-8 anti-death receptor 5 antibody in combination with chemotherapy in an ex vivo human ovarian cancer model.
6/2008	Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5.
4/2008	Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.
3/2008	Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model.
12/2007	TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologically validated orthotopic pancreatic tumor growth.
9/2007	Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer.
5/2007	Efficacy of anti-death receptor 5 (DR5) antibody (TRA-8) against primary human ovarian carcinoma using a novel ex vivo tissue slice model.
4/2006	Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model.
9/2003	Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patsy G Oliver Research Topics

Disease

23	Neoplasms (Cancer) 10/2020 - 09/2003
8	Breast Neoplasms (Breast Cancer) 10/2020 - 09/2003
6	Pancreatic Neoplasms (Pancreatic Cancer) 07/2020 - 09/2007
4	Triple Negative Breast Neoplasms 10/2020 - 07/2014
3	Ovarian Neoplasms (Ovarian Cancer) 11/2018 - 05/2007
3	Adenocarcinoma 01/2018 - 01/2016
2	Neoplasm Metastasis (Metastasis) 03/2018 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 01/2017
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2008 - 04/2006
1	Inflammation (Inflammations) 01/2017
1	Carcinogenesis 01/2016
1	Glioma (Gliomas) 06/2008
1	Colonic Neoplasms (Colon Cancer) 04/2008
1	Carcinoma (Carcinomatosis) 05/2007

Drug/Important Bio-Agent (IBA)

10	tigatuzumabIBA 06/2012 - 09/2003
9	Monoclonal AntibodiesIBA 03/2018 - 09/2003
8	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 07/2009 - 04/2006
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 03/2005
4	Gemcitabine FDA Link 01/2018 - 12/2007
4	Adenosine Triphosphate (ATP)IBA 01/2016 - 05/2007
4	LigandsIBA 03/2011 - 03/2005
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2011 - 03/2005
3	RNA (Ribonucleic Acid)IBA 01/2017 - 07/2014
3	Paclitaxel (Taxol)FDA LinkGeneric 06/2012 - 09/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2012 - 09/2003
2	Transcription Factors (Transcription Factor)IBA 10/2020 - 01/2016
2	Phenobarbital (Luminal)FDA Link 10/2020 - 01/2017
2	EnzymesIBA 07/2020 - 01/2016
2	Carboplatin (JM8)FDA LinkGeneric 11/2018 - 07/2009
2	SRI36160IBA 01/2018 - 01/2017
2	Estrogen ReceptorsIBA 01/2017 - 07/2014
2	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2016 - 01/2015
2	Death Domain ReceptorsIBA 07/2009 - 04/2008
2	Irinotecan (Camptosar)FDA LinkGeneric 04/2008 - 09/2007
2	Cisplatin (Platino)FDA LinkGeneric 03/2008 - 04/2006
1	ChromatinIBA 10/2020
1	Estrogen Receptor alphaIBA 10/2020
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2020
1	purineIBA 07/2020
1	Tamoxifen FDA LinkGeneric 11/2018
1	SphingosineIBA 11/2018
1	Selective Estrogen Receptor Modulators (SERM)IBA 11/2018
1	LipidsIBA 11/2018
1	CeramidesIBA 11/2018
1	Fingolimod Hydrochloride (FTY720)FDA Link 11/2018
1	Indicators and Reagents (Reagents)IBA 03/2018
1	chondroitin sulfate proteoglycan 4IBA 03/2018
1	SialyltransferasesIBA 01/2018
1	beta CateninIBA 01/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2017
1	AminesIBA 01/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2017
1	BenzimidazolesIBA 01/2017
1	CateninsIBA 01/2017
1	benzimidazoleIBA 01/2017
1	AngiopoietinsIBA 10/2016
1	GlycosyltransferasesIBA 01/2016
1	Sialic AcidsIBA 01/2016
1	triphenylphosphoniumIBA 01/2016
1	Sulfhydryl Compounds (Thiols)IBA 01/2016
1	Aconitate Hydratase (Aconitase)IBA 01/2016
1	Glycoproteins (Glycoprotein)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 07/2014
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2014
1	Albumin-Bound Paclitaxel FDA Link 06/2012
1	AntibodiesIBA 03/2011
1	Temozolomide (Temodar)FDA LinkGeneric 06/2008
1	TRA-8 monoclonal antibodyIBA 12/2007
1	CaspasesIBA 05/2007
1	Small Heat-Shock ProteinsIBA 03/2005
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2005
1	CytokinesIBA 03/2005
1	Caspase 3 (Caspase-3)IBA 03/2005
1	alpha-Crystallin B ChainIBA 03/2005

Therapy/Procedure

12	Therapeutics 10/2020 - 03/2005
6	Drug Therapy (Chemotherapy) 06/2012 - 09/2003
3	Radiotherapy 06/2008 - 09/2003
1	Radioimmunotherapy 03/2018
1	Precision Medicine 01/2018
1	Hysterectomy 03/2008
1	Aftercare (After-Treatment) 09/2007
1	Injections 09/2007
1	Cytoreduction Surgical Procedures 05/2007